All Companies

LLY

Eli Lilly & Co.

Pharmaceutical Preparations

$1,154.97updated Jul 31, 2026

Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.

Total Trades

50

Politicians Trading

21

Last Traded

Jul 10, 2026

Price history

Congressional Trades

PoliticianNotifiedTradedTypeAmountChange
Dan NewhouseRJul 17, 2026Jul 10, 2026Sell$1,001 - $15,000-2.83%
Gilbert Ray Cisneros, Jr.DJul 2, 2026Jun 10, 2026Buy$50,001 - $100,000+1.64%
Byron DonaldsRMay 13, 2026Apr 2, 2026Buy$1,001 - $15,000+23.45%
Byron DonaldsRMay 13, 2026Apr 2, 2026Buy$1,001 - $15,000+23.45%
Alan ArmstrongRJul 21, 2026Mar 27, 2026Sell$1,001 - $15,000+31.51%
David TaylorRMar 6, 2026Feb 26, 2026Buy$1,001 - $15,000+13.01%
David TaylorRFeb 20, 2026Feb 9, 2026Sell$1,001 - $15,000+10.56%
David TaylorRFeb 2, 2026Jan 16, 2026Sell$1,001 - $15,000+11.23%
Markwayne MullinRJan 16, 2026Dec 29, 2025Buy$15,001 - $50,000+7.07%
Angus S. King Jr.IJan 26, 2026Dec 29, 2025Buy$1,001 - $15,000+7.07%
Julie JohnsonDJan 15, 2026Dec 18, 2025Sell$1,001 - $15,000+9.28%
David TaylorRDec 19, 2025Dec 10, 2025Sell$1,001 - $15,000+16.24%
John BoozmanRDec 8, 2025Nov 21, 2025Sell$1,001 - $15,000+8.99%
Gilbert Ray Cisneros, Jr.DDec 15, 2025Nov 18, 2025Buy$1,001 - $15,000+12.13%
Julie JohnsonDDec 11, 2025Nov 13, 2025Sell$1,001 - $15,000+12.91%
Shelley Moore CapitoRNov 4, 2025Oct 24, 2025Buy$1,001 - $15,000+39.92%
Val T. HoyleDOct 10, 2025Sep 23, 2025Sell$1,001 - $15,000+54.62%
John BoozmanRSep 12, 2025Aug 22, 2025Buy$1,001 - $15,000+62.29%
David TaylorRSep 2, 2025Aug 14, 2025Buy$1,001 - $15,000+68.75%
David TaylorRSep 2, 2025Aug 14, 2025Buy$15,001 - $50,000+68.75%
Julie JohnsonDSep 11, 2025Aug 14, 2025Sell$1,001 - $15,000+68.75%
John BoozmanRSep 12, 2025Aug 11, 2025Buy$1,001 - $15,000+81.82%
Lisa C. McClainRAug 13, 2025Jul 16, 2025Sell$1,001 - $15,000+46.24%
Lisa C. McClainRAug 13, 2025Jul 10, 2025Buy$1,001 - $15,000+46.08%
Lisa C. McClainRAug 13, 2025Jun 9, 2025Sell$1,001 - $15,000+49.28%
Jonathan L. JacksonDJul 14, 2025Jun 3, 2025Sell$15,001 - $50,000+53.84%
Gilbert Ray Cisneros, Jr.DJun 6, 2025May 30, 2025Sell$1,001 - $15,000+56.57%
Jonathan L. JacksonDAug 25, 2025May 21, 2025Sell$1,001 - $15,000+59.32%
Marjorie Taylor GreeneRMay 19, 2025May 14, 2025Buy$1,001 - $15,000+61.41%
Josh GottheimerDJun 11, 2025May 13, 2025Sell$1,001 - $15,000+54.81%
Jefferson ShreveRJun 22, 2025May 12, 2025Sell$100,001 - $250,000+52.86%
Val T. HoyleDSep 12, 2025May 6, 2025Sell$1,001 - $15,000+49.01%
Marjorie Taylor GreeneRMay 6, 2025May 5, 2025Buy$1,001 - $15,000+40.60%
Josh GottheimerDJun 11, 2025May 1, 2025Buy$1,001 - $15,000+45.44%
Jonathan L. JacksonDAug 25, 2025Apr 23, 2025Buy$1,001 - $15,000+39.25%
Jonathan L. JacksonDMay 13, 2025Apr 21, 2025Buy$15,001 - $50,000+41.19%
Bruce WestermanRMay 12, 2025Apr 21, 2025Sell$1,001 - $15,000+41.19%
Tommy TubervilleRMay 15, 2025Apr 15, 2025Sell$15,001 - $50,000+52.54%
Dan NewhouseRMay 16, 2025Apr 11, 2025Sell$1,001 - $15,000+57.69%
Josh GottheimerDMay 14, 2025Apr 9, 2025Sell$1,001 - $15,000+53.24%
Robert BresnahanRApr 28, 2025Apr 8, 2025Sell$1,001 - $15,000+59.03%
Julie JohnsonDMay 14, 2025Apr 7, 2025Sell$1,001 - $15,000+59.59%
Josh GottheimerDApr 10, 2025Mar 10, 2025Sell$1,001 - $15,000+39.19%
Ashley MoodyRMar 22, 2025Mar 6, 2025Buy$100,001 - $250,000+26.54%
Bruce WestermanRApr 16, 2025Mar 3, 2025Buy$1,001 - $15,000+24.23%
Josh GottheimerDMar 6, 2025Feb 19, 2025Sell$1,001 - $15,000+33.21%
Ron WydenDFeb 21, 2025Feb 10, 2025Sell$50,001 - $100,000+32.93%
Ron WydenDFeb 21, 2025Jan 22, 2025Buy$50,001 - $100,000+53.18%
Marjorie Taylor GreeneRJan 27, 2025Jan 21, 2025Buy$1,001 - $15,000+55.58%
Josh GottheimerDFeb 10, 2025Jan 8, 2025Sell$1,001 - $15,000+46.72%